Fruquintinib in Refractory Metastatic Colorectal Cancer: A Real-world Study
NCT06202417
·
clinicaltrials.gov ↗
COMPLETED
Status
520
Enrollment
OTHER
Sponsor class
Conditions
Colorectal Cancer
Refractory Colorectal Cancer
Metastatic Colorectal Cancer
Interventions
DRUG:
Fruquintinib
Sponsor
Fudan University